Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

47.61
-0.8900-1.84%
Post-market: 47.610.00000.00%17:40 EST
Volume:32.75K
Turnover:1.57M
Market Cap:1.62B
PE:22.88
High:49.03
Open:48.50
Low:47.41
Close:48.50
52wk High:56.59
52wk Low:39.58
Shares:34.00M
Float Shares:27.67M
Volume Ratio:0.61
T/O Rate:0.12%
Dividend:2.99
Dividend Rate:6.28%
EPS(TTM):2.08
EPS(LYR):2.41
ROE:13.77%
ROA:3.98%
PB:2.67
PE(LYR):19.76

Loading ...

Omada Health’s Surge in App Downloads and GLP-1 Care Track Expansion Justify Buy Rating

TIPRANKS
·
Oct 13, 2025

Is Global Partners (GLP) Now Undervalued? A Fresh Look at the Company’s Recent Valuation

Simply Wall St.
·
Oct 11, 2025

GLP-1 Dark Horse Files Hong Kong IPO Application with $500 Million Post-Money Valuation

Deep News
·
Oct 09, 2025

Tariffs and GLP-1s are keeping people from dining out. An analyst tries to find the positives.

Dow Jones
·
Oct 09, 2025

Advancing Oral GLP-1 and Oncology Trials Might Change The Case For Investing In Sino Biopharm (SEHK:1177)

Simply Wall St.
·
Oct 07, 2025

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01

GlobeNewswire
·
Oct 01, 2025

Pfizer's Ultra-Long-Acting GLP-1 Achieves Positive Results in Two Phase II Weight Loss Studies

Stock News
·
Sep 30, 2025

Why This Beaten-Down GLP-1 Stock Could Be a Steal

Motley Fool
·
Sep 30, 2025

New Stock Preview | Leveraging the GLP-1 Wave, Can XianWeida Biology Successfully Enter the Hong Kong Stock Exchange?

Stock News
·
Sep 30, 2025

Viking Therapeutics: Promising Position in GLP-1 Market with Strategic Growth Potential

TIPRANKS
·
Sep 29, 2025

Autonomix launches GLP study for Sensing and RF ablation system

TIPRANKS
·
Sep 29, 2025

Are These GLP-1 Trial Results About to Send Eli Lilly's Stock Soaring?

Motley Fool
·
Sep 28, 2025

Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet?

Motley Fool
·
Sep 27, 2025

Positive Outlook on Regeneron Amidst EYLEA Challenges: Strategic Focus on GLP-1 Therapies for Alzheimer’s

TIPRANKS
·
Sep 26, 2025

Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know.

Motley Fool
·
Sep 26, 2025

Small Nucleic Acid Drugs Poised to Become New Trend in Weight Loss Market, Combination with GLP-1 May Address Multiple Clinical Needs

Stock News
·
Sep 26, 2025

Global GP LLC Reports Acquisition of Common Shares of Global Partners LP

Reuters
·
Sep 26, 2025

Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity

GlobeNewswire
·
Sep 23, 2025

Hong Kong Stock Movement | PEGBIO CO-B (02565) Surges Over 5% in Morning Trading, Advanced Clinical Progress in GLP-1 Multi-Target Field with PB-718 as Key Pipeline Product

Stock News
·
Sep 23, 2025

SINO BIOPHARM (01177): TQF3250 Capsule "GLP-1 Receptor Agonist" Clinical Trial Application Accepted by NMPA

Stock News
·
Sep 22, 2025